GSA Capital Partners’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
14,986,947
+11,732,714
+361% +$3.27M 0.16% 99
2026
Q1
$1.07M Buy
3,254,233
+3,202,373
+6,175% +$5.03M 0.07% 459
2025
Q4
$161K Sell
51,860
-138,955
-73% -$396K 0.01% 1463
2025
Q3
$502K Sell
190,815
-569,633
-75% -$1.26M 0.04% 845
2025
Q2
$935K Buy
760,448
+64,895
+9% +$70.8K 0.07% 504
2025
Q1
$765K Sell
695,553
-166,860
-19% -$193K 0.07% 514
2024
Q4
$780K Buy
862,413
+794,867
+1,177% +$681K 0.06% 574
2024
Q3
$67K Buy
+67,546
New +$65K 0.01% 1510
2023
Q3
Sell
-484,822
Closed -$582K 1650
2023
Q2
$582K Buy
484,822
+459,346
+1,803% +$572K 0.06% 647
2023
Q1
$32K Sell
25,476
-101,021
-80% -$193K ﹤0.01% 1414
2022
Q4
$274K Buy
126,497
+85,228
+207% +$702K 0.03% 997
2022
Q3
$494K Buy
41,269
+19,447
+89% +$241K 0.07% 579
2022
Q2
$183K Buy
21,822
+2,115
+11% +$16.4K 0.03% 1093
2022
Q1
$171K Buy
+19,707
New +$190K 0.02% 1209
2021
Q4
Sell
-10,578
Closed -$133K 1555
2021
Q3
$133K Buy
+10,578
New +$97.4K 0.01% 1296
2021
Q2
Sell
-38,506
Closed -$356K 1418
2021
Q1
$356K Buy
+38,506
New +$388K 0.06% 546
2020
Q4
Sell
-63,461
Closed -$788K 1353
2020
Q3
$788K Buy
63,461
+49,448
+353% +$656K 0.13% 178
2020
Q2
$182K Sell
14,013
-22,088
-61% -$278K 0.1% 374
2020
Q1
$366K Buy
+36,101
New +$471K 0.09% 347

Other funds holding GOSS

GSA Capital Partners's GOSS Position: Q2 2026 in Review

GSA Capital Partners increased its Gossamer Bio (GOSS) stake by 361% in Q2 2026, buying an estimated $3.27M and bringing the position to 14,986,947 shares worth $2.47M. The position accounts for 0.16% of the portfolio, ranked #99.

GSA Capital Partners first reported a position in GOSS in Q1 2020 and has held it in 19 quarters since. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • GSA Capital Partners held 14,986,947 shares of Gossamer Bio worth $2.47M as of Q2 2026.
  • GSA Capital Partners bought 11,732,714 Gossamer Bio shares in Q2 2026, an estimated $3.27M.
  • Gossamer Bio made up 0.16% of GSA Capital Partners's portfolio in Q2 2026, its #99 holding.
  • GSA Capital Partners first reported a position in Gossamer Bio in Q1 2020 and has held it in 19 quarters since.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.